Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma-Reference-Cited by-同舟云学术

Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma

Published:2021-03-25 Issue:14 Volume:27 Page:3854-3860
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Van Tine Brian A.^ORCID,Hirbe Angela C.^ORCID,Oppelt Peter,Frith Ashley E.,Rathore Richa^ORCID,Mitchell Joshua D.^ORCID,Wan Fei,Berry Shellie,Landeau Michele,Heberton George A.^ORCID,Gorcsan John,Huntjens Peter R.^ORCID,Soyama Yoku,Vader Justin M.^ORCID,Alvarez-Cardona Jose A.,Zhang Kathleen W.^ORCID,Lenihan Daniel J.^ORCID,Krone Ronald J.

Funder

National Center for Advancing Translational Sciences of the NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection Using Doxorubicin: The Role of Dexrazoxane;Pharmaceutical Science;2024-07-10

2. Marein Alleviates Doxorubicin-Induced Cardiotoxicity through FAK/AKT Pathway Modulation while Potentiating its Anticancer Activity;Cardiovascular Toxicology;2024-06-19

3. Cardiac Safety of Pegylated Liposomal Doxorubicin After Conventional Doxorubicin Exposure in Patients With Sarcoma and Breast Cancer;Cureus;2023-09-07

4. Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma;Cancer Management and Research;2023-06

5. Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas:Post HocAnalysis of a Prospective Randomized Trial (SARC021/TH CR-406);Clinical Cancer Research;2023-01-09